Open access
Oct 2026
TRIM29 may facilitate progression of pancreatic ductal adenocarcinoma through immune remodeling.
This study identifies TRIM29 as a machine learning-prioritized diagnostic biomarker and functional regulator of PDAC progression and immune remodeling, suggesting its potential value for biomarker-guided risk assessment and therapeutic exploration in PDAC.
Shuai-Wu Luo, Yong-Hao Xu, Wen-Jun Liao et al.
· Pancreatology : official jou... · 0 citations